Clinical Trial Update: Study of Desmoteplase (International Nonproprietary Name [INN]) in Acute Ischemic Stroke (DIAS-2) [Phase 3]

View source ↗

Summary

This entry reports the completion of the Phase 3 DIAS-2 trial evaluating desmoteplase for acute ischemic stroke.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Desmoteplase (Desmoteplase)

Snippet

Sponsor: Forest Laboratories | Conditions: Stroke, Acute | Phase 3 | Status: COMPLETED